| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/24/1998 | US5721225 Skin disorders; osteoporosis |
| 02/24/1998 | US5721224 Method of treating metabolic bone diseases with 18-nor-vitamin D compounds |
| 02/24/1998 | US5721211 Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 02/24/1998 | US5721207 Administering elcatonin in acceptable vehicle by intrathecal route |
| 02/24/1998 | US5720975 Use of incense in the treatment of alzheimer's disease |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720304 Diagnosis by conventional medical technique or bi-digital-o-ring test; having patient ingest antibiotic or antiviral agent, also ingest a herb concentration of umbelliferae family over sustained period of time |
| 02/24/1998 | CA2075750C Composition and method for treating cancer |
| 02/19/1998 | WO1998006864A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006846A1 Human induced tumor protein |
| 02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
| 02/19/1998 | WO1998006830A1 Synthetic polynucleotides |
| 02/19/1998 | WO1998006746A2 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 02/19/1998 | WO1998006741A1 Thrombin inhibitors |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006441A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006425A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 02/19/1998 | WO1998006424A1 Cancerous metastasis inhibitors for oral administration |
| 02/19/1998 | WO1998006264A1 Plasmin-depletion therapy |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
| 02/19/1998 | WO1997038085A3 Genes amplified in cancer cells |
| 02/19/1998 | DE19632773A1 Neue Thrombininhibitoren New thrombin inhibitors |
| 02/19/1998 | CA2263706A1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | CA2263416A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 02/19/1998 | CA2263220A1 Thrombin inhibitors |
| 02/19/1998 | CA2263172A1 Two human nsp-like proteins |
| 02/19/1998 | CA2263165A1 Human induced tumor protein |
| 02/19/1998 | CA2262524A1 Gnrh-leukotoxin chimeras |
| 02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
| 02/18/1998 | EP0823913A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 02/18/1998 | EP0823908A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 02/18/1998 | EP0823901A1 Quinazoline derivative |
| 02/18/1998 | EP0823900A1 Quinazoline derivatives |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | EP0609217B1 Dry starch-iodine pharmaceutical formulations |
| 02/18/1998 | CN1173874A Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compsns containing same |
| 02/18/1998 | CN1173873A Novel farnesyl transferase inhibitors, proparation thereof, and pharmaceutical compositions containing same |
| 02/18/1998 | CN1173817A Method, compsns and kits for increasing the oral bioavilability of pharmaceuticalagents |
| 02/18/1998 | CN1173497A Heterocycle-containing carbonic acid derivatives |
| 02/18/1998 | CN1173351A Recovery liquid for cancer and tumour |
| 02/17/1998 | US5719265 Antitumor agents with improved water solubility and reduced toxicity |
| 02/17/1998 | US5719185 Use for GABA agonists for treating emesis |
| 02/17/1998 | US5719177 Antitumor agents |
| 02/17/1998 | US5719175 Protein kinase C inhibitors |
| 02/17/1998 | US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them |
| 02/17/1998 | US5719148 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/17/1998 | US5719135 Tyrosine kinase inhibitors |
| 02/17/1998 | US5719125 Human chondromodulin-I protein |
| 02/17/1998 | CA1339679C Reduced size lhrh analogs |
| 02/12/1998 | WO1998005792A2 A novel human leptin receptor gene-related protein |
| 02/12/1998 | WO1998005787A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/12/1998 | WO1998005786A2 Afc1 and rce1:isoprenylated caax processing enzymes |
| 02/12/1998 | WO1998005783A1 A tumor necrosis factor related ligand |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005769A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 02/12/1998 | WO1998005684A2 Mhc binding peptide oligomers and methods of use |
| 02/12/1998 | WO1998005669A1 Total synthesis of antitumor acylfulvenes |
| 02/12/1998 | WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | WO1998005353A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS |
| 02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
| 02/12/1998 | WO1998005347A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 02/12/1998 | WO1998005336A1 Inhibitors of cysteine protease |
| 02/12/1998 | WO1998005335A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) |
| 02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | WO1998005315A1 Pentafluorobenzenesulfonamides and analogs |
| 02/12/1998 | WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 02/12/1998 | WO1997019111A3 Monoclonal antibodies anti-cd6 and their uses |
| 02/12/1998 | DE19652183C1 Treating oestrogen-dependent tumour with Cimicifuga racemosa extract |
| 02/12/1998 | CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | CA2262648A1 Total synthesis of antitumor acylfulvenes |
| 02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
| 02/12/1998 | CA2262517A1 Afc1 and rce1:isoprenylated caax processing enzymes |
| 02/12/1998 | CA2262405A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2262223A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof |
| 02/12/1998 | CA2261783A1 1,2-diarylindole as cox-2 inhibitors |
| 02/12/1998 | CA2261573A1 A novel human leptin receptor gene-related protein |
| 02/12/1998 | CA2260742A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0823438A2 Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 02/11/1998 | EP0823437A2 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/11/1998 | EP0822993A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1 |
| 02/11/1998 | EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822983A1 Apopain |
| 02/11/1998 | EP0822831A1 Vaccines containing a saponin and a sterol |
| 02/11/1998 | EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 02/11/1998 | CN1173206A Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
| 02/11/1998 | CN1173170A Matrix metalloprotease inhibitors |
| 02/11/1998 | CN1173134A Use of incense in the treatment of alzheimer's disease |
| 02/11/1998 | CN1173128A Polynucleotide compositions |
| 02/11/1998 | CN1172793A 1, 25 -dihydroxy -16, 22, 23 -trisdehydro-chdecalciferol derivatives |
| 02/11/1998 | CN1172650A Medicine for guiding cancer cell differentiation and its use on treating and prevent cancer |
| 02/10/1998 | US5717113 Antitumor agents |
| 02/10/1998 | US5717099 Method of synthesis for 6,9-bis((2-aminoethyl)amino)benzo g!isoquinoline-5,10-dione and its dimaleate salt |